<DOC>
	<DOCNO>NCT01566799</DOCNO>
	<brief_summary>Background Obesity overweight well know risk factor breast cancer also associate high recurrence mortality rate . Main goal study evaluate efficacy metformin plus chemotherapy term pathologic complete response comparison placebo plus chemotherapy regimen Design : Randomized , double blind , clinical trial . This study perform National Cancer Institute Mexico City , breast cancer unit . Patients ER+ PR+ , HER2 negative , breast cancer candidate participate . After completion chemotherapy patient breast surgery ass pathologic response . Complete pathologic response define abscence malignant cell breast tissue lymph node . The presence DCIS consider pCR</brief_summary>
	<brief_title>Metformin Plus Neoadjuvant Chemotherapy Breast Cancer</brief_title>
	<detailed_description>Definitions Luminal A : tumor ER + PR + HER2 Negative Ki67 &lt; 14 % Luminal B : tumor ER +/- , PR +/- , HER2 negative Ki67 &gt; 15 % Complete pathologic response define abscence malignant cell breast tissue lymph node . The presence DCIS consider pCR</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Women older 18 year old young 70 year old Invasive breast cancer confirm core biopsy , histology Tumor ≥2 cm and/or lymph node positive ( proven FNA ) ( T24b , N03 , M0 ) Must ER/PR positive HER2 negative Must full staging extent disease clinically radiographically tumor measure Without previous treatment breast cancer ( include surgery , hormonotherapy chemotherapy ) Normal liver , kidney blood test Performance Status ECOG 02 Karnofsky ≥70 % Fasten glucose level &lt; 125 mg/dl Signed consent Previous use metformin indication Presence Diabetes Mellitus</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Locally advanced breast cancer</keyword>
	<keyword>Neoadjuvant chemotherapy</keyword>
	<keyword>Metformin</keyword>
	<keyword>Pathologic Complete Response</keyword>
</DOC>